Showing results (351-360 of 361) with videos related to

Sort By:
Pageof 37
British Journal of Cancer|October 31, 2021
miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcomeMaria-Alexandra Papadimitriou, Aristea-Maria Papanota, Panagiotis G Adamopoulos, et al.
Biomedicines|December 24, 2021
tRNA Derivatives in Multiple Myeloma: Investigation of the Potential Value of a tRNA-Derived Molecular SignatureParaskevi Karousi, Aristea-Maria Papanota, Pinelopi I Artemaki, et al.
International Journal of Molecular Sciences|December 10, 2021
A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple MyelomaAristea-Maria Papanota, Paraskevi Karousi, Christos K Kontos, et al.
International Journal of Molecular Sciences|March 17, 2019
Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder CancerAikaterini F Giannopoulou, Athanassios D Velentzas, Eumorphia G Konstantakou, et al.
Biological Chemistry|June 28, 2006
A comprehensive nomenclature for serine proteases with homology to tissue kallikreinsAke Lundwall, Vimla Band, Michael Blaber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2015
The Stat3/5 Signaling Biosignature in Hematopoietic Stem/Progenitor Cells Predicts Response and Outcome in Myelodysplastic Syndrome Patients Treated with AzacitidineParaskevi Miltiades, Eleftheria Lamprianidou, Theodoros P Vassilakopoulos, et al.
The Science of the Total Environment|October 8, 2021
SARS-CoV-2 wastewater surveillance data can predict hospitalizations and ICU admissionsAikaterini Galani, Reza Aalizadeh, Marios Kostakis, et al.
International Journal of Molecular Sciences|February 24, 2019
Gene-Specific Intron Retention Serves as Molecular Signature that Distinguishes Melanoma from Non-Melanoma Cancer Cells in Greek PatientsAikaterini F Giannopoulou, Eumorphia G Konstantakou, Athanassios D Velentzas, et al.
Vaccines|April 3, 2021
SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody ResponseOurania E Tsitsilonis, Dimitrios Paraskevis, Evi Lianidou, et al.
Oncotarget|September 19, 2015
Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysisClaudio Luchini, Nicola Veronese, Marco Solmi, et al.
Pageof 37